CC02 - Bringing injection therapy forward- Discussion on leveraging the new FITTER Forward recommendations to improve patient care outcomes

Thursday, November 27, 2025

11:55 - 12:15 Toronto

Location: CC Theatre 2

Sponsored By

Speaker(s)

Akshay Jain, MD, FRCPC, FACE, ECNU, DABIM, DABOM

Endocrinologist
UNIVERSITY OF BRITISH COLUMBIA
University of British Columbia
Surrey, British Columbia, Canada

Disclosure(s): Abbott: Advisory Board (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (Ongoing); Abbvie: Speaker/Honoraria (Ongoing); Amgen: Advisory Board (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (Ongoing); Astra Zeneca: Advisory Board (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (Ongoing); Bausch Healthcare: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Bayer: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Boehringer Ingelheim: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); CPD network: Speaker/Honoraria (Ongoing); Dexcom: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Diabetes Canada: Speaker/Honoraria (Ongoing); Eisai: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Eli Lilly: Advisory Board (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (Ongoing); gsk: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); HLS Therapeutics: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Insulet: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); MDBriefcase: Speaker/Honoraria (Ongoing); medtronic: Speaker/Honoraria (Ongoing); Moderna: Speaker/Honoraria (Ongoing); Novo Nordisk: Advisory Board (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (Ongoing); Partners in Progressive Medical Education: Consultant (Ongoing); Pfizer: Speaker/Honoraria (Ongoing); PocketPills: Advisory Board (Ongoing); roche: Advisory Board (Ongoing); Sandoz: Advisory Board (Ongoing); sanofi aventis: Grant/Research Support (Ongoing), Speaker/Honoraria (Ongoing); Takeda: Advisory Board (Ongoing); Timed Right: Speaker/Honoraria (Ongoing); ypsomed: Advisory Board (Ongoing)
Lori Berard, Nurse Consultant (she/her/hers)

Nurse Consultant
Independent
Winnipeg, Manitoba, Canada

Disclosure(s): Bayer: Committee/Planning Member (Ongoing), Consultant (Ongoing), Speaker/Honoraria (Ongoing); Dexcom Canada: Consultant (Ongoing), Speaker/Honoraria (Ongoing); Eli Lilly: Speaker/Honoraria (Ongoing); EMBECTA: Consultant (Ongoing), Speaker/Honoraria (Ongoing); MontMed: Consultant (Ongoing), Speaker/Honoraria (Ongoing); Novo Nordisk: Consultant (Ongoing), Speaker/Honoraria (Ongoing); Sanofi: Consultant (Ongoing)

Disclosure(s):

Akshay Jain, MD, FRCPC, FACE, ECNU, DABIM, DABOM: Abbott: Advisory Board (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (Ongoing); Abbvie: Speaker/Honoraria (Ongoing); Amgen: Advisory Board (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (Ongoing); Astra Zeneca: Advisory Board (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (Ongoing); Bausch Healthcare: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Bayer: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Boehringer Ingelheim: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); CPD network: Speaker/Honoraria (Ongoing); Dexcom: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Diabetes Canada: Speaker/Honoraria (Ongoing); Eisai: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Eli Lilly: Advisory Board (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (Ongoing); gsk: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); HLS Therapeutics: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); Insulet: Advisory Board (Ongoing), Speaker/Honoraria (Ongoing); MDBriefcase: Speaker/Honoraria (Ongoing); medtronic: Speaker/Honoraria (Ongoing); Moderna: Speaker/Honoraria (Ongoing); Novo Nordisk: Advisory Board (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (Ongoing); Partners in Progressive Medical Education: Consultant (Ongoing); Pfizer: Speaker/Honoraria (Ongoing); PocketPills: Advisory Board (Ongoing); roche: Advisory Board (Ongoing); Sandoz: Advisory Board (Ongoing); sanofi aventis: Grant/Research Support (Ongoing), Speaker/Honoraria (Ongoing); Takeda: Advisory Board (Ongoing); Timed Right: Speaker/Honoraria (Ongoing); ypsomed: Advisory Board (Ongoing)

Lori Berard, Nurse Consultant: Bayer: Committee/Planning Member (Ongoing), Consultant (Ongoing), Speaker/Honoraria (Ongoing); Dexcom Canada: Consultant (Ongoing), Speaker/Honoraria (Ongoing); Eli Lilly: Speaker/Honoraria (Ongoing); EMBECTA: Consultant (Ongoing), Speaker/Honoraria (Ongoing); MontMed: Consultant (Ongoing), Speaker/Honoraria (Ongoing); Novo Nordisk: Consultant (Ongoing), Speaker/Honoraria (Ongoing); Sanofi: Consultant (Ongoing)

Learning Objectives: Navigating the FITTER Forward Recommendations
Factors influencing injection experience
Evidence-based injection technique procedures
Risk reduction and detection of lipohypertrophy
Structured training for optimal outcomes

This is an unaccredited activity sponsored by Embecta. This activity is not part of the 2025 Diabetes Canada/CSEM accredited educational programming as planned by the Diabetes Canada/CSEM Scientific Planning Committee and does not qualify for Maintenance of Certification credits.